Minnesota Clinical Investigator Site Prism Clinical Research Acquired by Private Equity-Backed Australian CRO

Minnesota Clinical Investigator Site Prism Clinical Research Acquired by Private Equity-Backed Australian CRO

Clinical investigator site consolidation continues as deal making goes international. Crescent Capital Partner-backed Australian dedicated research site and contract research organization (CRO) Nucleus Network recently acquired St. Paul MN-based Prism Clinical...
DURECT Launches Phase Ib NASH Clinical Trial

DURECT Launches Phase Ib NASH Clinical Trial

Streetwise Reports notes DURECT Corp. (DRRX: NASDAQ) is enrolling patients in its Phase Ib non-alcoholic steatohepatitis (NASH) trial. A multicenter, open-label study will evaluate the company’s lead drug, DUR-928, in patients with NASH. A total of 60 patients will be...
Incyte Phase I Adult Cancer Trial Bring Hope

Incyte Phase I Adult Cancer Trial Bring Hope

MDLinx reports that a unique Phase I trial will commence at 4 centers nationwide. Unlike most Phase I cancer studies, this specific study is not organ specific.  Meaning, that patients with any solid tumor may participate (e.g cervical cancer, gastric cancer,...

Pin It on Pinterest